• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和疾病状态对非甾体抗炎药相关性胃出血的影响

Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.

作者信息

Llewellyn J G, Pritchard M H

机构信息

Department of Rheumatology, University Hospital of Wales, Heath Park, Cardiff, UK.

出版信息

J Rheumatol. 1988 Apr;15(4):691-4.

PMID:3397979
Abstract

In our study of 552 acute admissions for gastrointestinal hemorrhage, 18% were found to be taking nonsteroidal antiinflammatory drugs (NSAID) at the time of the bleed; 49% of these were found at endoscopy to have a gastric or prepyloric lesion, compared with 20% of the non-NSAID control group. Prescription data was used to calculate the risk added by age and disease state to the NSAID associated bleeding. We found that patients with chronic inflammatory disease had 2-3 times the expected bleeding incidence, but while there was a definite trend towards an age related risk in older patients, this was not statistically significant.

摘要

在我们对552例急性胃肠道出血入院病例的研究中,发现18%的患者在出血时正在服用非甾体抗炎药(NSAID);在内镜检查中,这些患者中有49%存在胃或幽门前病变,而非NSAID对照组的这一比例为20%。利用处方数据计算年龄和疾病状态给NSAID相关出血增加的风险。我们发现,患有慢性炎症性疾病的患者出血发生率是预期的2至3倍,然而,虽然老年患者存在与年龄相关风险的明确趋势,但这在统计学上并不显著。

相似文献

1
Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding.年龄和疾病状态对非甾体抗炎药相关性胃出血的影响
J Rheumatol. 1988 Apr;15(4):691-4.
2
The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.类风湿关节炎中非甾体抗炎药相关性胃病的兴衰
Arthritis Rheum. 2004 Aug;50(8):2433-40. doi: 10.1002/art.20440.
3
Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.在8538名使用塞来昔布、罗非昔布和非选择性非甾体抗炎药(NSAID)的患者以及接受普通临床护理的未使用NSAID的患者中,血压不稳定和水肿情况。
J Rheumatol. 2004 Jun;31(6):1143-51.
4
The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.类风湿关节炎和骨关节炎患者胃肠道不良事件的比较风险及预测因素:一项对2131例患者进行的为期13年的前瞻性研究
J Rheumatol. 2000 Jul;27(7):1668-73.
5
[NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].[类风湿性关节炎和心血管疾病患者的非甾体抗炎药处方]
Reumatizam. 2006;53(1):22-4.
6
Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.荟萃分析:与非特异性非甾体抗炎药相比,环氧化酶-2特异性抑制剂伐地昔布在骨关节炎和类风湿关节炎患者中的上消化道耐受性。
Aliment Pharmacol Ther. 2005 Mar 1;21(5):591-8. doi: 10.1111/j.1365-2036.2005.02383.x.
7
Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.风湿科医生对米索前列醇用于非甾体抗炎药相关性胃病高危患者的指南的遵循情况。
J Rheumatol. 2002 Feb;29(2):339-46.
8
Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.上消化道出血患者使用非处方非甾体抗炎药的惊人流行率。
Arch Intern Med. 1994 Jan 10;154(1):42-6.
9
Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.非甾体抗炎药所致胃病的并发症及胃黏膜保护的应用:一家三级医疗保健中心的经验
J Rheumatol. 1999 Jul;26(7):1557-63.
10
Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.一项为期六个月的前瞻性研究,以监测缓释氟比洛芬治疗风湿性疾病的效果。
Drugs Exp Clin Res. 2000;26(1):19-24.

引用本文的文献

1
Aging enhances susceptibility of diclofenac-treated rats to gastric ulceration, while attenuating enteropathy.衰老增强了双氯芬酸处理的大鼠对胃溃疡的易感性,同时减轻了肠道病变。
Dig Dis Sci. 2000 Mar;45(3):614-20. doi: 10.1023/a:1005422029918.
2
Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.多病共存患者、老年人群及其他高危群体的疼痛治疗。降低毒性的临床挑战。
Drug Saf. 1998 Jun;18(6):457-72. doi: 10.2165/00002018-199818060-00006.
3
[Risk of ulcer and its prophylaxis in therapy with non-steroidal antirheumatic drugs].
[非甾体类抗风湿药物治疗中溃疡的风险及其预防]
Med Klin (Munich). 1997 Dec 15;92(12):726-35. doi: 10.1007/BF03044669.
4
Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events.类风湿关节炎的关节外表现:严重胃肠道事件的危险因素
Ann Rheum Dis. 1993 Nov;52(11):771-5. doi: 10.1136/ard.52.11.771.
5
In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients?
Clin Rheumatol. 1990 Sep;9(3):315-8. doi: 10.1007/BF02114390.
6
Effect of colloidal bismuth subcitrate on age related gastric lesions in the rat.枸橼酸铋钾对大鼠年龄相关性胃损伤的影响。
Gut. 1991 Apr;32(4):355-60. doi: 10.1136/gut.32.4.355.